Searchable abstracts of presentations at key conferences in endocrinology

ea0016p243 | Diabetes and cardiovascular diseases | ECE2008

Gestational diabetes has no additional effect on plasma thrombin-activatable fibrinolysis inhibitor antigen levels beyond pregnancy

Akinci Baris , Demir Tevfik , Saygili Saba , Yener Serkan , Alacacioglu Inci , Saygili Fatih , Bayraktar Firat , Yesil Sena

Pregnancy is a prothrombotic condition with increased levels of several circulating coagulation factors. The aim of the present study is to investigate the effect of gestational diabetes on plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels.Plasma TAFI and PAI-1 antigen levels were measured in 26 pregnant women with gestational diabetes, 25 pregnant women with normal glucose tolerance, and age matched 24 non-pregnant women with no h...